CAPR Competitors & Alternatives
Compare Capricor Therapeutics Inc with similar stocks in the same industry
Biotechnology
CAPR
Main Stock$8.37
Tradestie Score
32
Market Cap
$357.51M
Revenue Growth
-0.1%
Analyst Upside
+240.5%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.00
|
$512.39M | - | 48 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$47.24
|
$505.12M | 2.8 | 47 | Compare |
|
RGNX
REGENXBIO Inc.
|
$8.53
|
$493.52M | - | 47 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$109.27
|
$492.21M | - | 40 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$8.21
|
$468.01M | - | 47 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$14.07
|
$463.20M | - | 65 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$8.70
|
$457.09M | - | 40 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$6.53
|
$454.29M | - | 42 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 50 | Compare |
More CAPR Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)
239 stocks in this industry